Immiscible phase nucleic acid purification eliminates PCR inhibitors with a single pass of paramagnetic particles through a hydrophobic liquid.

Extraction and purification of nucleic acids from complex biological samples for PCR are critical steps because inhibitors must be removed that can affect reaction efficiency and the accuracy of results. This preanalytical processing generally involves capturing nucleic acids on microparticles that are then washed with a series of buffers to desorb and dilute out interfering substances. We have developed a novel purification method that replaces multiple wash steps with a single pass of paramagnetic particles (PMPs) though an immiscible hydrophobic liquid. Only two aqueous solutions are required: a lysis buffer, in which nucleic acids are captured on PMPs, and an elution buffer, in which they are released for amplification. The PMPs containing the nucleic acids are magnetically transported through a channel containing liquid wax that connects the lysis chamber to the elution chamber in a specially designed cartridge. Transporting PMPs through the immiscible phase yielded DNA and RNA as pure as that obtained after extensive wash steps required by comparable purification methods. Our immiscible-phase process has been applied to targets in whole blood, plasma, and urine and will enable the development of faster and simpler purification systems.

[1]  L. Jagodzinski,et al.  Use of Calibrated Viral Load Standards for Group M Subtypes of Human Immunodeficiency Virus Type 1 To Assess the Performance of Viral RNA Quantitation Tests , 2000, Journal of Clinical Microbiology.

[2]  Helen H. Lee,et al.  Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings. , 2007, The Analyst.

[3]  Jon Dobson,et al.  Structural and magnetic properties of nanoscale iron oxide particles synthesized in the presence of dextran or polyvinyl alcohol , 2001 .

[4]  M. Salimans,et al.  Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.

[5]  R. Badaró,et al.  Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil. , 2006, Journal of virological methods.

[6]  H. Gendelman,et al.  Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus , 1986, The Journal of experimental medicine.

[7]  W. Preiser,et al.  Extraction buffer contaminated bacterially as a cause of invalid HIV-1 viral load results on the NucliSens EasyQ system. , 2008, Journal of virological methods.

[8]  Gavin Cloherty,et al.  Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR , 2007, Nucleic acids research.

[9]  Isolation and purification of nucleic acids , 2002 .

[10]  C. Sangregorio,et al.  A new method for the synthesis of magnetoliposomes , 1999 .

[11]  Michael G. Roper,et al.  A fully integrated microfluidic genetic analysis system with sample-in–answer-out capability , 2006, Proceedings of the National Academy of Sciences.

[12]  J. Rich,et al.  Plasma viral load testing in the management of HIV infection. , 2001, American family physician.

[13]  S. Berensmeier Magnetic particles for the separation and purification of nucleic acids , 2006, Applied Microbiology and Biotechnology.

[14]  M. Senna,et al.  Magnetic properties of ultrafine magnetite particles and their slurries prepared via in-situ precipitation , 1996 .

[15]  B. Diedrich,et al.  Characteristics of the m2000 Automated Sample Preparation and Multiplex Real-Time PCR System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae , 2007, Journal of Clinical Microbiology.

[16]  R. Molday,et al.  Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. , 1982, Journal of immunological methods.

[17]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[18]  J. Read Diagnosis of HIV-1 Infection in Children Younger Than 18 Months in the United States , 2007, Pediatrics.

[19]  J. Hackett,et al.  Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays. , 2006, Journal of virological methods.

[20]  V. Calvez,et al.  Stability of HIV RNA in plasma specimens stored at different temperatures , 2008, HIV medicine.

[21]  K. Landfester,et al.  Encapsulated magnetite particles for biomedical application , 2003 .

[22]  P. Mitchell Microfluidics—downsizing large-scale biology , 2001, Nature Biotechnology.

[23]  Cheryl Jennings,et al.  HIV-1 Viral Load Assays for Resource-Limited Settings , 2006, PLoS medicine.

[24]  D. Erickson,et al.  Integrated microfluidic devices , 2004 .